Drugs and medicines
13 June 2019
A practical update for busy paediatricians on managing day-to-day common outpatient and ward clinical dilemmas and issues.
29 March 2019
Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.
The use of unlicensed medicines or licensed medicines for unlicensed applications in paediatric practice
This statement, originally produced in 2000, was updated in 2013 by the Joint Standing Committee on Medicines, a committee of the Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group. The update reflects changes in European (including UK) law that aim to fa...
Our free resource, launched in March 2019, brings together examples of quality improvement (QI) interventions submitted by child health professionals. It also has useful tools to aid data collection and improvement interventions.
1 February 2019
We have worked with NHS England on a programme to ensure children and young people with a learning disability, autism or both are able to access appropriate medication, and are not prescribed inappropriate psychotropic medication. Find out more and read our full pledge.
The Neonatal and Paediatric Pharmacists Group and RCPCH strongly recommend that when children require unlicensed liquid medications, they should receive the RCPCH and NPPG recommended strength where one exists. There are currently 17 such recommended strengths detailed below, 16 of which are publish...
The aim of this evidence-based statement is to summarise the current knowledge about delayed prescriptions (also called backup prescriptions) for antibiotics and to highlight the special issues that must be taken into account when considering the need for a delayed prescription in infants and childr...
6 December 2018
A new feature for our 2019 RCPCH Conference and exhibition, these talks will showcase the latest ideas and discoveries in child health.
30 October 2018
RCPCH responds to new research which suggests these drugs may alter gut microbes associated with weight gain.
The following case study from Calderdale and Huddersfield NHS Foundation Trust was included in the 2018 annual report on 2017 data, and highlights how NNAP results can be used as a basis for identifying, and undertaking, local quality improvement activities.